SCHEMBL3261373

SCHEMBL3261373

COc1ccc(C(=O)NCCc2c(C)[nH]c3c(Cl)cc(Cl)cc23)cc1OC

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.57
KDM4E B2RXH2 2/20 0.57
ALDH1A1 P00352 2/20 0.57
MAPK1 P28482 1/20 0.57
MTNR1A P48039 2/20 0.53
MTNR1B P49286 2/20 0.53
GAA P10253 1/20 0.53
MAPT P10636 3/20 0.52
RAB9A P51151 2/20 0.52
NPC1 O15118 1/20 0.52
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
TSHR P16473 1/20 0.47
TP53 P04637 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
HTT P42858 1/20 0.46
POLB P06746 1/20 0.46
SNCA P37840 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3260174 0.90 LMNA (0.55) LMNAKDM4EALDH1A1MAPK1MTNR1A
SCHEMBL3261033 0.90 LMNA (0.55) LMNAKDM4EALDH1A1MAPK1MTNR1A
SCHEMBL3264647 0.89 MAPT (0.57) LMNAKDM4EALDH1A1MAPK1MTNR1A
SCHEMBL3260936 0.85 LMNA (0.54) LMNAKDM4EALDH1A1MAPK1MTNR1A
SCHEMBL3261480 0.84 LMNA (0.55) LMNAKDM4EALDH1A1MAPK1MTNR1A
SCHEMBL758858 0.84 PSEN1 (0.69) LMNAKDM4EALDH1A1MAPK1MTNR1A
SCHEMBL3638149 0.83 MEN1 (0.53) LMNAKDM4EALDH1A1MAPK1MTNR1A
SCHEMBL3260613 0.83 MEN1 (0.58) LMNAKDM4EALDH1A1MAPK1MTNR1A
SCHEMBL3262940 0.83 ALDH1A1 (0.56) LMNAKDM4EALDH1A1MAPK1MTNR1A
SCHEMBL3264356 0.83 KDM4E (0.56) LMNAKDM4EALDH1A1MAPK1MTNR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010012396-A1 5,6 SUBSTITUTED BENZAMIDE DERIVATIVES AS MODULATORS OF THE EP<SB>2 </SB>RECEPTOR BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-02-04 WO claimed
EP-2149552-A1 5,6 substituted benzamide derivatives as modulators of EP2 receptors Bayer Schering Pharma AG (DE) 2010-02-03 EP claimed
WO-2010012396-A1 5,6 SUBSTITUTED BENZAMIDE DERIVATIVES AS MODULATORS OF THE EP<SB>2 </SB>RECEPTOR BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-02-04 WO disclosed
EP-2149552-A1 5,6 substituted benzamide derivatives as modulators of EP2 receptors Bayer Schering Pharma AG (DE) 2010-02-03 EP disclosed
EP-2149552-A1 5,6 substituted benzamide derivatives as modulators of EP2 receptors Bayer Schering Pharma AG (DE) 2010-02-03 EP disclosed